Maria Lia Palomba

Summary

Affiliation: Memorial Sloan-Kettering Cancer Center
Country: USA

Publications

  1. ncbi CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma
    Maria Lia Palomba
    Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 11:370-9. 2005
  2. ncbi Active Immunotherapy: Current State of the Art in Vaccine Approaches for NHL
    M Lia Palomba
    Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Curr Oncol Rep 14:433-40. 2012

Research Grants

  1. CD20 DNA VACCINATION FOR B-CELL LYMPHOMA
    Maria Palomba; Fiscal Year: 2007

Detail Information

Publications2

  1. ncbi CD8+ T-cell-dependent immunity following xenogeneic DNA immunization against CD20 in a tumor challenge model of B-cell lymphoma
    Maria Lia Palomba
    Department of Medicine and Immunology Program, Memorial Sloan Kettering Cancer Center, New York, New York 10021, USA
    Clin Cancer Res 11:370-9. 2005
    ..These results show that active immunization with xenogeneic DNA vaccines can induce CD8+ T cell-dependent immunity against CD20...
  2. ncbi Active Immunotherapy: Current State of the Art in Vaccine Approaches for NHL
    M Lia Palomba
    Lymphoma Service, Memorial Sloan Kettering Cancer Center, New York, NY, USA
    Curr Oncol Rep 14:433-40. 2012
    ..What follows is a brief summary of the historical highlights in lymphoma immunotherapy as well as an update on the most recently published clinical trials and a look at future developments...

Research Grants2

  1. CD20 DNA VACCINATION FOR B-CELL LYMPHOMA
    Maria Palomba; Fiscal Year: 2007
    ..Furthermore, she proposes to explore the effect of CD20 immunization in the post-bone marrow transplant settings. Finally, the candidate proposes to carry out a phase I clinical trial of CD20 DNA vaccine in patients with lymphoma. ..